TOWARD AN ECONOMIC FRAMEWORK FOR UNDERSTANDING PERFORMANCE-BASED RISK-SHARING AGREEMENTS FOR INNOVATIVE MEDICAL PRODUCTS

被引：1
|
作者：
Garrison, L. P. [1 ]
Towse, A. [2 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Off Hlth Econ, London, England
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75309-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A488 / A488
页数：1
相关论文
共 50 条
  • [41] TOWARD PERFORMANCE-BASED CONTINUING MEDICAL-EDUCATION
    GEYMAN, JP
    [J]. JOURNAL OF FAMILY PRACTICE, 1977, 5 (03): : 333 - 333
  • [42] It Takes 2 to Tango. Setting Out the Conditions in Which Performance-Based Risk-Sharing Arrangements Work for Both Parties
    Towse, Adrian
    Fenwick, Elisabeth
    [J]. VALUE IN HEALTH, 2024, 27 (08) : 1058 - 1065
  • [43] PAY-FOR-PERFORMANCE RISK-SHARING ARRANGEMENTS FOR MEDICAL TECHNOLOGY IN CHINA: APPLICATION AND PROSPECT
    Ai, Y.
    Wang, J.
    Zhao, J.
    Ming, J.
    Liu, J.
    Hu, M.
    Chen, Y.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S302 - S302
  • [44] Performance-Based Risk-Sharing Arrangements (PBRSA): Is it a Solution to Increase Bang for the Buck for Pharmaceutical Reimbursement Strategy for Our Nation and Around the World?
    Andy Eunwoo Kim
    David Hohyun Choi
    Jongwha Chang
    Sean Hyungwoo Kim
    [J]. Clinical Drug Investigation, 2020, 40 : 1107 - 1113
  • [45] Performance-Based Risk-Sharing Arrangements (PBRSA): Is it a Solution to Increase Bang for the Buck for Pharmaceutical Reimbursement Strategy for Our Nation and Around the World?
    Kim, Andy Eunwoo
    Choi, David Hohyun
    Chang, Jongwha
    Kim, Sean Hyungwoo
    [J]. CLINICAL DRUG INVESTIGATION, 2020, 40 (12) : 1107 - 1113
  • [46] INNOVATIVE, OUTCOMES-BASED RISK-SHARING CONTRACTS AS A SOLUTION WITHIN THE GERMAN AMNOG PROCESS?
    Spelsberg, R.
    Walzer, S.
    [J]. VALUE IN HEALTH, 2020, 23 : S654 - S654
  • [47] Implementing outcomes-based risk-sharing agreements: an integrative review of applications in blood cancer in the UK and beyond
    Bayani, Diana Beatriz
    Wee, Hwee Lin
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (08) : 879 - 889
  • [48] Regulatory, Policy, and Operational Considerations for Outcomes-Based Risk-Sharing Agreements in the US Market: Opportunities for Reform
    Goodman, Clifford
    Villarivera, Christel
    Gregor, Karl
    van Bavel, Julie
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (11): : 1174 - 1181
  • [49] FASTER ACCESS TO INNOVATIVE THERAPIES WITH RISK-SHARING AGREEMENTS - CANCER MEDICATION REIMBURSEMENT DECISIONS FROM JANUARY 2012 TO NOVEMBER 2021 IN FINLAND
    Ihalmo, P.
    Vaatainen, S.
    Soini, E.
    Vandorou, C.
    Mankinen, P.
    Nevalainen, E.
    Price, M.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S287 - S287
  • [50] DARVADSTROCEL IN THE MANAGEMENT OF COMPLEX PERIANAL FISTULAS: THE ROLE OF PATIENT REGISTRY DATA COLLECTION TO SUPPORT PERFORMANCE-BASED RISK SHARING AGREEMENTS
    Schmetz, A.
    Petrakis, I
    Khalid, J. M.
    Minda, K.
    Agboton, C.
    Rawson, K.
    Baumgart, D. C.
    [J]. VALUE IN HEALTH, 2018, 21 : S147 - S148
12345